BIO-B vs TXG
Bio-Rad Laboratories, Inc. Class B Common Stock · 10x Genomics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | BIO-B | TXG |
|---|---|---|
| Price | $337.00 | $58.15 |
| Market Cap | $9.32B | $7.43B |
| P/E | 12.27 | — |
| P/B | 1.36 | 9.12 |
| P/S | 3.61 | 11.55 |
| ROE | 11.1% | -5.3% |
| Net Margin | 29.4% | -6.8% |
| Gross Margin | 51.9% | 69.1% |
| Revenue Growth | 0.7% | 5.2% |
| Dividend Yield | — | — |
| EPS | $27.46 | -$0.34 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.